drugset / Trial / NCT06038474
Descartes-08 for Patients With Systemic Lupus Erythematosus
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase II study to evaluate the safety, tolerability and manufacturing feasibility of Descartes-08 CAR T-cells in patients with Systematic Lupus erythematosus (SLE).
Timeline
- Start
- 2024-02-12
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Descartes-08 | Cell therapy | — | — |